Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Samsung Biologics (207940 KS)
Watchlist
524
Analysis
Health Care
•
South Korea
Samsung Biologics Co.,Ltd. manufactures bio-healthcare products. The Company develops, refines, and distributes biopharmaceutical products.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Thematic (Sector/Industry)
•
27 Nov 2025 00:09
•
Broker
Mirae Asset Minutes [2025: Volume 22]Biweekly strategy meeting recap
We expect AI adoption to drive meaningful price, volume, and cost improvements in 2026, supporting strong momentum in the ad segment.
Mirae Asset Securities
Follow
285 Views
Share
bullish
•
Thematic (Sector/Industry)
•
12 Nov 2025 20:52
•
Broker
Mirae Asset Minutes [2025: Volume 21]Biweekly strategy meeting recap
With the BOK expected to keep the base rate unchanged through 2H25, market interest rates have begun to rise. This is favorable for banks’ NIMs.
Mirae Asset Securities
Follow
210 Views
Share
bullish
•
Thematic (Sector/Industry)
•
31 Oct 2025 19:58
•
Broker
Mirae Asset Minutes [2025: Volume 20]Biweekly strategy meeting recap
Global equities are likely to remain on an upward trend, supported by favorable liquidity conditions and optimism surrounding AI ecosystem growth
Mirae Asset Securities
Follow
529 Views
Share
bullish
•
Thematic (Sector/Industry)
•
29 Oct 2025 19:45
•
Broker
Mirae Asset Minutes [2025: Volume 20] Biweekly Strategy Meeting Recap
Global equities are likely to remain on an upward trend, supported by favorable liquidity conditions and optimism surrounding AI ecosystem growth
Mirae Asset Securities
Follow
514 Views
Share
bullish
•
Thematic (Sector/Industry)
•
15 Oct 2025 19:52
•
Broker
Mirae Asset Minutes [2025: Volume 19]Biweekly strategy meeting recap
While AI-related demand from hyperscalers and governments is surging, demand for commodity memory remains uncertain, leading to limited capacity...
Mirae Asset Securities
Follow
476 Views
Share
Previous
1
2
3
4
5
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x